Genitourinary Cancer Clinical Trials and Research

Short placeholder heading

We conduct clinical research and investigations to improve our ability to diagnose and treat patients with all genitourinary malignancies. This research is important, because it aims to improve current and future cancer treatments and care.

Our physicians and researchers conduct ongoing research studies, including:

  • investigations of prevention and early-detection strategies
  • assessment of new therapies
  • quality-of-life studies
  • analysis of tissue, blood, and tumor samples to better understand the biology of the malignancies and relation to patient outcomes

If you are a new patient, we may ask you to participate in one of these studies. 

Learn more about participating in a clinical trial.

Prostate, Bladder, and Kidney Cancer Research Studies

As a Dana-Farber patient, you may be asked to participate in a research study designed to help doctors and scientists understand the basic biology and genetics of prostate and renal cancer, which ultimately may help people in the future.

During your appointment, a study coordinator will meet with you to discuss the study and answer your questions. Your participation is completely voluntary and will not affect your medical care or benefits should you decide not to participate.

Find out more about prostate, bladder, and kidney cancer research studies.

The Arthur and Linda Gelb Center for Translational Research

With the cooperation of more than 8,000 patients, the Arthur and Linda Gelb Center for Translational Research has steadily built a deep clinical database and collection of genitourinary tumor samples.

Research using these samples has yielded significant data about the development and treatment of prostate, kidney, and bladder cancers, helping scientists study possible links between genes and genitourinary cancers.

Such efforts are designed to develop better, more effective treatments for cancer and related malignancies.

Learn more about the Gelb Center.

Rare Genitourinary Cancers

Imagine having a cancer so rare, trials don't exist for you. That's been the case for years for patients with certain genitourinary cancers. Now, a first of its kind trial at Dana-Farber Cancer Institute offers a potential turning point and the opportunity to try a promising therapy.

Featured Genitourinary Cancer Clinical Trials